Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.0B | 5.0B | 4.2B | 4.5B |
| Cost of revenue | 1.8B | 2.3B | 1.9B | 2.2B |
| Gross profit | 2.2B | 2.7B | 2.3B | 2.3B |
| Operating expense | ||||
| Research & development | 373M | 355M | 343M | 442M |
| Selling general and admin | 1.5B | -1.9B | 1.4B | 1.5B |
| Other operating expenses | -2M | 11M | — | 2M |
| Operating income | 215M | 597M | 459M | 285M |
| Non operating interest income | ||||
| Income | 121M | — | — | — |
| Expense | 228M | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 114M | 503M | 371M | 144M |
| Tax provision | 25M | 111M | 82M | 32M |
| Net income | 89M | 392M | 289M | 112M |
| Basic EPS | 0.5 | — | 1.9 | 0.7 |
| Diluted EPS | 0.5 | — | 1.9 | 0.7 |
| Basic average shares | 145.6M | — | 145.6M | 145.6M |
| Diluted average shares | 145.6M | — | 145.7M | 145.6M |
| EBITDA | 681M | 977M | 717M | 699M |
| Net income from continuing op. | 215M | 601M | 516M | 284M |
| Minority interests | -18M | -25M | -18M | -16M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |